Neglected Tropical Diseases (NTDs) are a diverse group of parasitic, viral, and bacterial infections that affect more than a billion people worldwide, primarily in low-income regions. Common NTDs include dengue, leishmaniasis, lymphatic filariasis, schistosomiasis, and onchocerciasis. These diseases cause chronic illness, disability, and social stigma, disproportionately impacting vulnerable populations. Global strategies for NTD control focus on mass drug administration, vector control, improved sanitation, and health education, with growing support from international health organizations and governments.
Market Analysis: In 2025, the global market addressing NTDs—including diagnostics, drugs, vector management, and preventive care—is estimated at USD 2.7 billion. With sustained international funding, pharmaceutical innovations, and expanding public health initiatives, the market is projected to grow to USD 4.5 billion by 2030, reflecting a CAGR of 10.8%. Africa and South Asia remain the largest demand centers due to high disease prevalence, while Latin America and Southeast Asia show rising investments in elimination programs. Increasing partnerships between governments, NGOs, and biotech firms are expected to drive long-term growth.
